GlassScriptPhysician profile
Gianna P Casini
NPI 1194083121
$5,078.98
in general payments reported to CMS, 2019-2025
24 companies · $431 in 2025
The $431 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,396 · 2020: $755 · 2021: $214 · 2022: $157 · 2023: $404 · 2024: $723 · 2025: $431.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,558.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,557.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,287.37 | 2019-2025 | Intracept Rf Probe, Intracept, Wavewriter Alpha Prime 16 |
| Abbott Laboratories | $563.13 | 2019-2021 | |
| Medtronic USA, INC. | $457.99 | 2019-2020 | |
| Nevro Corp. | $402.14 | 2023-2024 | Senza |
| Medtronic, INC. | $236.49 | 2024 | Intellis Adaptivestim |
| Amgen INC. | $212.07 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $204.70 | 2019-2020 | |
| Abbvie INC. | $164.06 | 2022-2025 | Botox |
| Mml US, INC. | $130.65 | 2022 | |
| Novartis Pharmaceuticals Corporation | $71.69 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $60.29 | 2019-2024 | Belbuca |
| Teva Pharmaceuticals USA, INC. | $47.98 | 2019-2020 | |
| Lundbeck LLC | $31.14 | 2025 | Vyepti |
| Pfizer INC. | $30.82 | 2020-2025 | |
| Shockwave Medical, INC | $29.57 | 2025 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $24.43 | 2019 | |
| Stryker Corporation | $20.74 | 2025 | Mild Device Kit |
| Scilex Pharmaceuticals INC. | $18.05 | 2019 | |
| Saluda Medical Americas, INC. | $16.44 | 2024 | Evoke |
| Kaleo, INC. | $15.60 | 2019 | |
| Spr Therapeutics, INC | $15.55 | 2024 | Sprint Pns System |
| Alexion Pharmaceuticals, INC. | $14.80 | 2019 | |
| Bioventus LLC | $12.25 | 2022 | |
| Novo Nordisk INC | $11.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gianna Casini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.